Ganga Pharmaceuticals (BOM:539680) Research & Development: ₹0.00 Mil (TTM As of Mar. 2026)


BOM:539680 Ganga Pharmaceuticals Ltd BOM:539680
62 GF Score
Price ₹12.00
GF Value ₹11.85
! 3 Warning Signs
View Full Analysis

What is Ganga Pharmaceuticals Research & Development?

Ganga Pharmaceuticals BOM:539680 62 Research & Development is ₹0.00 Mil as of Mar. 2026. GuruFocus rates BOM:539680 with a GF Score™ of 62/100 and a GF Value™ of ₹11.85. The stock has 3 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Ganga Pharmaceuticals's Research & Development for the six months ended in Mar. 2026 was ₹0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was ₹0.00 Mil.

Ganga Pharmaceuticals  (BOM:539680) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Ganga Pharmaceuticals Research & Development Related Terms

Ganga Pharmaceuticals Research & Development Historical Data

* Premium members only.

The historical data trend for Ganga Pharmaceuticals's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ganga Pharmaceuticals Research & Development Chart

Ganga Pharmaceuticals Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Ganga Pharmaceuticals Semi-Annual Data
Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
BOM:539680
62GF Score
Ganga Pharmaceuticals Ltd BOM:539680
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ganga Pharmaceuticals Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was ₹0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of ₹0.00 Mil mean?
Ganga Pharmaceuticals (BOM:539680) has a Research & Development of ₹0.00 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Ganga Pharmaceuticals and its competitors.
Is Ganga Pharmaceuticals' Research & Development too high?
Ganga Pharmaceuticals' current Research & Development is ₹0.00 Mil. Overall, Ganga Pharmaceuticals has a GF Score™ of 62/100, reflecting its overall financial health beyond just this single metric.
How does Ganga Pharmaceuticals' Research & Development compare to ZTS?
Ganga Pharmaceuticals' Research & Development of ₹0.00 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Drug Manufacturers company?
A good Research & Development depends on the Drug Manufacturers industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Ganga Pharmaceuticals and its competitors. Ganga Pharmaceuticals's current Research & Development is ₹0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ganga Pharmaceuticals stock overvalued right now?
Ganga Pharmaceuticals (BOM:539680) has a current Research & Development of ₹0.00 Mil. The stock's GF Value™ is ₹11.85, compared to a current price of ₹12.00 — trading 1.3% above its estimated fair value. The current Research & Development is ₹0.00 Mil. Ganga Pharmaceuticals' overall GF Score™ is 62/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Ganga Pharmaceuticals (BOM:539680), the current Research & Development is ₹0.00 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Ganga Pharmaceuticals (BOM:539680) Overvalued in 2026?

Based on GuruFocus' analysis, Ganga Pharmaceuticals stock appears to be overvalued. The current stock price of ₹12.00 is trading 1.3% above its estimated GF Value™ of ₹11.85.

Key valuation signals for BOM:539680:

  • Research & Development: ₹0.00 Mil
  • GF Value™: ₹11.85 vs. price of ₹12.00 (1.3% above fair value)
  • GF Score™: 62/100 with 3 warning signs

No single metric tells the full story. See the BOM:539680 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Ganga Pharmaceuticals Business Description

Address Dhanvantri Marg, Gangatat, Gopcharpada, Near Digi 1 Electronic Showroom, Virar (East), Palghar, MH, IND, 401305
Ganga Pharmaceuticals Ltd is an India based producer of ayurvedic medicines. It is engaged in the business of manufacturing and trading in ayurvedic pharmaceuticals and allied products. The company is also involved in the marketing and distribution of bulk ayurvedic medicines. The firm offers ayurvedic medicines for acidity, anti-dandruff, anti-oxidants, dental care, diarrhea, iron tonic, liver disorder, weight management, kidney stone, joint pains, liver disorder and others.
62GF Score

Get the complete analysis for BOM:539680

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹12.00
Price
₹11.85
GF Value